drugset / Trial / NCT00269061

Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin

NCT00269061

Phase 1 Completed 32 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will use Magnetic Resonance Imaging (MRI) techniques to evaluate changes in fluid volume in the lower legs of diabetic patients who add either pioglitazone or placebo to their current diabetic regimen.

Timeline

Start
2006-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule